No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Times cited: 5
Prediction of breast cancer risk based on profiling with common genetic variants.
Journal of the National Cancer Institute.
Times cited: 209
Refined histopathological predictors of BRCA1 and BRCA2 mutation status: A large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia.
Breast Cancer Research.
Times cited: 40